Patents by Inventor Beau Gertz

Beau Gertz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRANASAL NALTREXONE
    Publication number: 20170020862
    Abstract: A stable transmucosal composition consisting essentially of naltrexone hydrochloride in water is provided. The composition is surprisingly stable at room temperature and can be used for simple, rapid and effective opioid overdose rescue.
    Type: Application
    Filed: May 19, 2016
    Publication date: January 26, 2017
    Inventors: Darby C. Brown, Jason Montgomery, Beau Gertz
  • INTRANASAL NALTREXONE
    Publication number: 20140249172
    Abstract: A stable transmucosal composition consisting essentially of naltrexone hydrochloride in water is provided. The composition is surprisingly stable at room temperature and can be used for simple, rapid and effective opioid overdose rescue.
    Type: Application
    Filed: May 16, 2014
    Publication date: September 4, 2014
    Applicant: 3B Pharmaceuticals, Inc.
    Inventors: Darby C. Brown, Jason Montgomery, Beau Gertz
  • INTRANASAL NALTREXONE
    Publication number: 20140171458
    Abstract: A stable transmucosal composition consisting essentially of naltrexone hydrochloride in water is provided. The composition is surprisingly stable at room temperature and can be used for simple, rapid and effective opioid overdose rescue.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 19, 2014
    Applicant: 3B Pharmaceuticals, Inc.
    Inventors: Darby C. Brown, Jason Montgomery, Beau Gertz